Business Context and Reporting Period
This Form 8-K is a current report filed by Keros Therapeutics, Inc. on May 27, 2021. The filing serves as a Regulation FD disclosure regarding an upcoming corporate presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an event notification and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates are reported in this document. The sole material event is the scheduling of a management presentation.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Jasbir Seehra, President and Chief Executive Officer, is scheduled to present at the Jefferies Virtual Healthcare Conference.
- Date and Time: Tuesday, June 1, 2021, at 2:00 PM EST.
- Disclosure Status: The press release (Exhibit 99.1) is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the Jefferies Virtual Healthcare Conference presentation (June 1, 2021, 2:00 PM EST).
- Review the attached press release (Exhibit 99.1) for specific details on the presentation agenda.
- Confirm that no financial data is included in this specific 8-K filing.